相关实验视频

Updated: May 14, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

绘制基因地图,建立一个有利于抗PD-1反应的瘤免疫微环境

Daniel A Skelly¹, John P Graham¹, Mingshan Cheng²

¹The Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME 04609, USA.

|May 9, 2025

概括

主体遗传学显著影响免疫检查点抑制剂 (ICI) 治疗反应. 这项研究确定了在小鼠模型中影响抗PD-1 (aPD1) 免疫治疗有效性的特定遗传位置和途径.

科学领域:

免疫学免疫学免疫学
遗传学遗传学是一个
在瘤学瘤学.

背景情况:

确定影响免疫检查点抑制剂 (ICI) 疗效的宿主遗传因素至关重要,但在实验上很困难.
现有的模型经常混宿主和瘤遗传学,限制了对宿主特异性影响的研究.

研究的目的:

开发和利用遗传资源来剖析宿主基因在调节ICI反应中的作用.
确定特定的定量特征位点 (QTL) 和决定对抗PD-1 (aPD1) 免疫疗法的反应的潜在基因.

主要方法:

采用协作交叉小鼠遗传资源来分离宿主和瘤遗传.
在四种不同的小鼠瘤模型中分析了对抗PD-1 (aPD1) 免疫疗法的反应.
为MC38结直肠癌模型绘制了QTL和在已识别的基因位点内研究了基因表达.

主要成果:

发现免疫检查点抑制剂 (ICI) 反应在不同模型中具有显著的遗传性 (H²: 0.18-0.40).
在MC38系统中绘制了四个显著的ICI响应QTL与表皮性相互作用.
这些QTL中的基因被丰富为抗原处理,呈现和与免疫相关的途径 (p < 1 × 10-10).
阻断GM-CSF和IL-2RB在MC38瘤中取消了对aPD1治疗的转录反应.

结论:

协作交叉平台有效地发现影响ICI疗效的宿主遗传因素.
宿主基因在塑造瘤免疫微环境和对免疫疗法的反应方面发挥着重要作用.
已识别的基因标为增强抗PD-1 (aPD1) 治疗结果提供了新的途径.

关键词:

CP: 癌症癌症癌症 CP: 免疫学免疫学在 QTL 映射中使用 QTL 地图.遗传学遗传学遗传学是一个遗传性遗传性遗传性免疫疗法免疫疗法鼠标模型鼠标模型瘤免疫的微环境

更多相关视频

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...